Skip to main content

Advertisement

Fig. 1 | BMC Neurology

Fig. 1

From: Sleep quality, daytime sleepiness, fatigue, and quality of life in patients with multiple sclerosis treated with interferon beta-1b: results from a prospective observational cohort study

Fig. 1

Course of fatigue (MFIS), functional health (SF-36), sleepiness (ESS), depression, and anxiety (HADS) throughout the study. Numbers of good sleepers (PSQI< 5) and poor sleepers (PSQI≥5) do not add up to number of all patients due to missing PSQI baseline values

MFIS Modified Fatigue Impact Scale, SF-36 Short Form-36, PCS physical component score, MCS mental component score, ESS Epworth Sleepiness Scale, HADS Hospital Anxiety and Depression Scale.

Back to article page